Company · CIK 0000879169 · SIC 8731 — Services-Commercial Physical & Biological Research · Nasdaq
INCYTE CORP · INCY
Insider activity reported against this company. All insider holders · Files at: AGEN, MRUS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 FForm 4 → | Sep 24, 4:06 pm EDT | David H GardnerEVP, Chief Strategy Officer | 920 | $126.93 | $116,776 | 15,904 | — | |
| Sep 15, 2026 SForm 4 → | Sep 17, 4:04 pm EDT | Pablo J CagnoniPresident, Global Head of R&D | 23,218 | $120.49 | $2,797,629 | 183,200 | −11.2% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 4:04 pm EDT | Pablo J CagnoniPresident, Global Head of R&D | 23,218 | $66.39 | $1,541,331 | 206,418 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:04 pm EDT | Pablo J CagnoniPresident, Global Head of R&D | 23,218 | — | — | 18,466 | — | 10b5-1 |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.